At a glance
- Originator sanofi-aventis
- Developer Sanofi
- Class Imidazoles
- Mechanism of Action Angiotensin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cardiovascular disorders
Most Recent Events
- 19 Jun 2008 AVE-0991 is still in preclinical trials for Cardiovascular disorders in Germany